The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
a company like Janentech um and many modern companies really like antibodies i like antibodies because when something happens it's on target it it doesn't tend to be offtarget small molecules that chemistry tends to have surprises in negative ways offtarget like liver toxicity or kidney toxicity
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Small molecules that chemistry tends to have surprises in negative ways offtarget like liver toxicity or kidney toxicity.